Safety, Tolerability and Pharmacokinetics Investigation of Stimotimagene Copolymerplasmid
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Sarcoma|Melanoma|Squamous Cell Carcinoma of Head and Neck|Breast Neoplasms|Uterine Cervical Neoplasms|Vulvar Neoplasms|Penile Neoplasms|Anus Neoplasms
Interventions: BIOLOGICAL: Intratumoral administration of Stimotimagene copolymerplasmid|DRUG: Intravenous administration of Ganciclovir (Cymeven®)
Sponsor: Gene Surgery LLC